| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, New Jersey 08854
 |
ABSTRACT |
|---|
 TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
In the
current study, the cardioprotective efficacy of 0.35 mmol/l
acetaminophen administered 10 min after the onset of a 20-min period of
global, low-flow myocardial ischemia was investigated. Matched
control hearts were administered an equal volume of Krebs-Henseleit physiological buffer solution (vehicle). In separate groups of hearts,
the concentration-dependent, negative inotropic properties of hydrogen
peroxide and the ability of acetaminophen to attenuate these actions,
as well as the effects of acetaminophen on
ischemia-reperfusion-mediated protein oxidation, were studied.
Acetaminophen-treated hearts regained a significantly greater fraction
of baseline, preischemia control function during reperfusion
than vehicle-treated hearts. For example, contractility [rate of
maximal developed pressure in the left ventricle
(±dP/dtmax)] after 10 min of reperfusion was
109 ± 24 and 42 ± 9 mmHg/s (P < 0.05),
respectively, in the two groups. The corresponding pressure-rate
products were 1,840 ± 434 vs. 588 ± 169 mmHg · beats · min
1 (P < 0.05). Acetaminophen attenuated peroxynitrite-mediated
chemiluminescence in the early minutes of reperfusion (e.g., at 6 min,
corresponding values for peak light production were ~8 × 106 counts/min for vehicle vs. <4 × 106
counts/min for acetaminophen, P < 0.05) and the
negative inotropic effects of exogenously administered hydrogen
peroxide (e.g., at 0.4 mmol/l hydrogen peroxide, pressure-rate
products were ~1.0 × 104 and 3.8 × 103 mmHg · beats · min1
in acetaminophen- and vehicle-treated hearts, respectively,
P < 0.05). Ischemia-mediated protein oxidation
was reduced by acetaminophen. The ability of acetaminophen to attenuate
the damaging effects of peroxynitrite and hydrogen peroxide and to
limit protein oxidation suggest antioxidant mechanisms are responsible
for its cardioprotective properties during
postischemia-reperfusion.
coronary circulation; ventricular function; peroxynitrite; hydrogen peroxide
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
ACETAMINOPHEN WAS INTRODUCED into Western medicine more than 100 years ago, and its pain-relieving and temperature-lowering actions have been under investigation for several decades (1, 9, 26). Potential cardiovascular properties of acetaminophen have gone undiscovered, in part, because no one has made an effort to do the experiments. This might have been influenced by standard textbooks of pharmacology that report that acetaminophen lacks efficacy in the cardiovascular system of mammals (12). The recent literature, however, suggests that investigators are beginning to fill this void. For example, Nakamoto et al. (22) reported beneficial effects of acetaminophen against gastric mucosal injury caused by ischemia-reperfusion in the rat. Farquhar et al. (10) reported reduced renal dysfunction in the stressed human kidney in the presence of acetaminophen vs. ibuprofen, and Colletti et al. (7) found that ibuprofen caused significantly greater renal arterial vasoconstriction than acetaminophen in sodium-depleted dogs.
One purpose of the current investigation was to determine whether administration of acetaminophen after the onset of low-flow myocardial ischemia could produce cardioprotection during the subsequent period of reperfusion. Another purpose was to investigate several antioxidant mechanisms that might help explain the cardioprotective properties of acetaminophen, e.g., does acetaminophen attenuate the negative inotropic actions of exogenously administered hydrogen peroxide? The latter objective seemed important because it is well known that hydrogen peroxide releases hydroxyl radical via the Fenton reaction (2, 14), and it has already been shown that acetaminophen attenuates the production of hydroxyl radical in the postischemic-reperfused myocardium (21).
| |
MATERIALS AND METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Animals and Heart Preparation
In adherence with National Institutes of Health/United States Department of Agriculture guidelines and after institutional review and approval, Hartley strain guinea pigs of both genders weighing 375 ± 25 g were obtained from Charles River Laboratories (Wilmington, MA). They were allowed several days to acclimate to the new housing conditions and were brought to the laboratory and euthanized by cranial crushing. Hearts were isolated, cannulated, and instrumented in situ as originally described by Bunger et al. (4, 5) and modified by Wei et al. (34). Instrumentation included inserting a flaccid latex balloon into the left atrium and advancing it across the mitral valve and into the left ventricle, where it was filled with Krebs-Henseleit buffer (KHB) solution to an end-diastolic pressure of 0-5 mmHg (volume of 75-100 µl). A pacing electrode was attached to the base of the right venticle, and a large-bore polyethylene (PE) cannula (PE-240) was inserted into the trunk of the pulmonary artery for collection of samples of coronary venous effluent perfusate. Normothermic heart temperature was confirmed by passing a thermistor probe into the right ventricle (model BAT-12, Physitemp; Clifton, NJ). Hearts were perfused retrogradely via the cannulated aorta without recirculation.Upon completion of the instrumentation, hearts were perfused in
increments of ~2 ml/min at 3- to 4-min intervals until a control rate
of 7-8 ml/min was reached. Flow was controlled at this rate throughout the experiments except during low-flow ischemia,
when it was reduced to 1 ml/min (model 291, Peri-Star pump, World
Precision Instruments; Sarasota, FL). Hearts were allowed 30 min of
postinstrumentation for monitored variables to achieve steady-state
conditions. Monitored variables included the following: heart rate (HR;
paced at a spontaneous rate plus 10%, in beats/min), left ventricular
developed pressure (LVDP; in mmHg, the difference between peak systolic
and end-diastolic pressures in the left ventricle), pressure-rate
product (PRP; i.e., LVDP × HR), rate of maximal developed
pressure (±dP/dtmax; in mmHg/s, contractility),
coronary perfusate flow rate (CPF; in ml/min), coronary perfusion
pressure (CPP; in mmHg), and calculated coronary vascular resistance
(CVR; in mmHg · ml1 · min).
Perfusate and Perfusion Modality
Perfusate was a modified KHB physiological solution (vehicle for acetaminophen) containing (in mmol/l) 128.0 NaCl, 4.7 KCl, 1.5 MgSO4 · 7H2O, 2.5 CaCl2, 1.2 KH2PO4, 24.9 NaHCO3, 10.0 glucose, and 2.0 pyruvate and 200 µU/ml insulin. It was warmed to 38°C and equilibrated with 95% O2-5% CO2 (pH 7.40 ± 0.02). Aortic flow (antegrade coronary flow) was achieved retrogradely from a water-jacketed 1.5-liter reservoir and was continuously monitored ultrasonically (model 2N423 flow probe and model T101 flowmeter, Transonic Systems; Ithaca, NY).Left ventricular pressures were monitored isovolumetrically (model
P231D, Gould-Statham; Oxnord, CA), and inflow (coronary arterial) and
outflow (pulmonary arterial, i.e., coronary venous) perfusate samples
were collected anaerobically for monitoring of pH and perfusate gases
(0.5-1.0 ml). Standard electrodes were used to measure
PO2 (in mmHg) and PCO2
(in mmHg) as well as pH, CO2 content, and base excess
(model 248 blood gases/pH analyzer, Bayer Diagnostics; Norwood, MA).
Perfusate arterial and coronary venous oxygen contents were calculated
as the products of PO2 and the solubility of
oxygen in physiological salt solution at 38°C as previously reported
by this laboratory (16, 20, 34). A solubility coefficient
of 2.28 × 102
µl · ml1 · mmHg1 was used
(29). From these data, oxygen supply, oxygen extraction, and oxygen consumption could be calculated.
Experimental Protocols
Four experimental protocols were completed. One protocol was to rule out time-dependent changes with acetaminophen. A second protocol was to determine the effects of acetaminophen on cardiac function and on peroxynitrite-mediated chemiluminescence during ischemia-reperfusion. The third protocol examined the effects of acetaminophen on the cardiac actions of exogenously administered hydrogen peroxide. A fourth experiment tested the effects of acetaminophen on ischemia-reperfusion-mediated protein oxidation. Details of each are given below.Time-dependent actions of acetaminophen and vehicle. All experiments in this investigation were conducted in either vehicle- or acetaminophen-treated hearts. In our laboratory, an average experiment in perfused guinea pig hearts lasted 90-120 min. After extraction and instrumentation, hearts in this protocol were allowed 30 min for monitored variables to achieve steady-state conditions. A sample of n = 10 hearts was used, 5 hearts each treated with vehicle or acetaminophen (0.35 mmol/l) immediately after collection of baseline, control data at the end of the 30-min stabilization period. Cardiac function, perfusate gases, pH, and coronary circulation were monitored at 15-min intervals during the 90-min experimental period.
Hydrogen peroxide and acetaminophen. A sample of n = 20 hearts was used in this experiment. In preliminary experiments (not included in the n = 20 hearts), we worked out a concentration-response profile for exogenously administered hydrogen peroxide. After baseline, control data were collected, either vehicle (n = 10 hearts) or acetaminophen (0.35 mmol/l; n = 10 hearts) was added to the perfusate reservoir. Hearts were allowed 20 min of exposure to either agent. Subsequently calculated volumes of a stock solution of hydrogen peroxide were added incrementally to the perfusate reservoir to yield final concentrations in the perfusate of 0.1, 0.25, and 0.4 mmol/l hydrogen peroxide. Hearts were allowed 15 min of exposure to each concentration before the next addition was made. Data were collected at the end of each of the 15-min periods for subsequent comparison.
Ischemia-reperfusion, peroxynitrite, and acetaminophen. The objective of this experiment was to determine whether administration of acetaminophen after 10 min of ischemia could produce beneficial, cardioprotective effects during the subsequent period of reperfusion. We also wanted to test the effects of acetaminophen on peroxynitrite-mediated oxidation of luminol, i.e., on the ability of effluent perfusate samples to produce chemiluminescence. A sample of n = 20 hearts was used. Ten hearts were treated with vehicle, and ten hearts were treated with acetaminophen (0.35 mmol/l). After collection of baseline, control data, hearts were submerged in physiological KHB (vehicle) at 38°C, and CPF was immediately reduced from 7-8 to 1 ml/min to produce low-flow, global myocardial ischemia. Normothermia was maintained throughout the period of ischemia to eliminate the confounding effects that result from hypothermic perfusion of the ischemic myocardium (i.e., as flow is reduced, the myocardial temperature can drop from 38 to <30°C over the course of 20 min, personal observations). During ischemia, data were collected at 5-min intervals. Subsequently, flow was restored to 7-8 ml/min, hearts were removed from the submersion fluid, i.e., the heart chamber was drained, and hearts were reperfused for 40 min. During reperfusion, data were collected at 10-min intervals.
Twenty additional hearts were divided into four groups of five hearts each as follows: vehicle treated (n = 5), acetaminophen treated (0.35 mmol/l, n = 5), urate treated (0.25 mmol/l, n = 5), and acetaminophen and urate-treated (n = 5). Urate was used to scavange peroxynitrite to aid in the identification of nonspecific chemiluminescence that might have been due to sources other than peroxynitrite. Retrieval of data included collection of coronary venous samples of perfusate (1 ml each) in all hearts under baseline, control conditions, at 10 and 20 min of ischemia, and at 1, 3, 6, 10, and 40 min of reperfusion. Samples were collected in prechilled vials and stored at
80°C for subsequent analysis of peroxynitrite and
chemiluminescence. Peroxynitrite and chemiluminescence were analyzed
following the published procedures of VanDyke et al. (30,
31) and Merrill et al. (21).
Ischemia-reperfusion, protein oxidation, and acetaminophen. One of the signs of protein damage caused by ischemia-reperfusion injury in the mammalian myocardium is the presence of increased carbonyls in the tissue. To investigate the influence of acetaminophen on ischemia-reperfusion-mediated protein damage, two groups of hearts were used: a vehicle-treated group (n = 12) and an acetaminophen-treated group (n = 12). A protocol similar to that described above for experiment 3 was used. In this experiment, however, tissue samples of the myocardium had to be collected at each of the experimental endpoints, i.e., control, baseline conditions, at the end of ischemia, and after 40 min of reperfusion. At each of these times, ventricles were quickly excised from the perfusion apparatus, blotted dry, and plunged into liquid nitrogen.
Protein oxidation, i.e., carbonyl contents of the myocardium, was analyzed according to the published procedures of Schacter et al. (28). Briefly, ventricular tissue was homogenized in HEPES suspension buffer containing protease inhibitors and then centrifuged to obtain the soluble fraction. Protein carbonyls were analyzed using a commercially available kit (OxyBlot, Intergen; Purchase, NY). Carbonyl groups on soluble cellular proteins were derived and then bound onto Zeta-Probe membranes using the Bio-Dot SF Microfiltration Apparatus (Bio-Rad Laboratories; Hercules, CA). The membrane-bound proteins were then blocked and probed with primary and secondary antibodies in blocking buffer. Membranes were developed using an avidin-biotin-horseradish peroxidase system and 3,3'-tetramethylbenzidine as substrate. The developed membranes were digitized and analyzed using computer-assisted densitometry (SigmaScan, Jandel Scientific; Chicago, IL).Statistical Analysis
All data were analyzed using analysis of variance for repeated measures. A priori tests, e.g., Tukey's w-procedure and Fisher's least-significant difference, were used to compare means. Statistically significant differences were established at P < 0.05, and all data are reported as means ± SE.| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Time-Dependent Actions of Acetaminophen and Vehicle
There were no statistically significant differences in any recorded variables between vehicle- and acetaminophen-treated hearts in this experiment (Table 1). Hearts were paced and on the average displayed rates of 270 ± 20 and 264 ± 16 beats/min in the two groups, respectively. There was some variability in HR (data not shown), but these values are consistent with previous data collected in our laboratory and elsewhere. Indexes of ventricular function, e.g., ±dP/dtmax, PRP, and LVDP, remained constant throughout the 90-min experimental period and did not vary in the two groups. However, there was a trend toward time-dependent improvement in ventricular function with acetaminophen that was not evident in vehicle-treated hearts, but this did not achieve significance (Table 1).
|
Ventricular wet weights were recorded at the end of each experiment in both groups. There were no differences, suggesting that whatever edema might have occurred with time was similar in both groups.
Hydrogen Peroxide and Acetaminophen
We chose the concentrations of 0.1, 0.25, and 0.4 mmol/l hydrogen peroxide because in preliminary experiments we found that concentrations up to and including 0.1 mmol/l had no effect on the myocardium. A concentration of 0.25 mmol/l consistently produced recordable negative inotropic effects, and 0.4 mmol/l produced marked, statistically significant, negative inotropism. These concentrations are also consistent with recent studies done by others (3, 6, 8, 14) in the rodent myocardium. After several minutes, concentrations >0.4 mmol/l regularly produced contracture, cardiac arrest, and ventricular fibrillation.The consistently most prominent effect of hydrogen peroxide was
concentration-dependent negative inotropy (Table
2). This effect was significantly
attenuated by acetaminophen. For example, all three indexes of
ventricular function were consistently reduced by 50-75% in
vehicle-treated hearts by the highest concentration of hydrogen
peroxide. Conversely, in acetaminophen-treated hearts, on the average,
the highest concentrations of hydrogen peroxide rarely reduced
function by >25% (Table 2). Figure
1 is a representative sample of the
effects of 0.4 mmol/l hydrogen peroxide on function and hemodynamic
variables in the presence of acetaminophen and vehicle. Note the
prominent and developing cardiac contracture in the presence of vehicle
and the evidence of reduced contractility.
|
|
Ischemia-Reperfusion, Peroxynitrite, and Acetaminophen
When administered midway through a 20-min period of ischemia, acetaminophen significantly preserved ventricular function during the subsequent period of reperfusion. For example, in acetaminophen-treated hearts, ±dP/dtmax was restored, on the average, to ~50% of its baseline, preischemia value throughout the 40-min period of reperfusion. Conversely, vehicle-treated hearts rarely recovered >20-25% of their baseline function during the same time interval. Figure 2 illustrates this in one vehicle-treated and one acetaminophen-treated heart. A similar picture emerged for other indexes of function, e.g., developed pressure, PRP, and ±dP/dtmax (Fig. 3). These physiological, functional differences were consistent with morphological changes seen under the two conditions. For example, electronmicrographs taken of the left ventricular free wall under baseline, control conditions and after 20 min of ischemia plus 40 min of reperfusion in the presence of vehicle and acetaminophen demonstrated the ability of acetaminophen to preserve left ventricular myofibrillar ultrastructure (Fig. 4, A-C).
|
|
|
During reperfusion, peroxynitrite-mediated oxidation of luminol
(chemiluminescence) was significantly attenuated by acetaminophen (Fig.
5). When hearts were treated with urate
with or without acetaminophen, luminol-mediated chemiluminescence
relative to vehicle-treated hearts was abolished, i.e., urate produced
the same effect as acetaminophen (Table
3).
|
|
There were no significant differences in perfusate gases, pH, and base
excess (comparing both arterial and coronary venous samples) in these
different groups of hearts (Table 4).
|
Ischemia-Reperfusion, Protein Oxidation, and Acetaminophen
Vehicle-treated hearts revealed a significantly greater (P < 0.05) content of protein carbonyls during ischemia than was seen in the presence of acetaminophen (Table 5). However, in both groups, protein carbonyls were still significantly elevated above corresponding baseline, control values after 40 min of reperfusion.
|
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
In an earlier experiment, the influences of pretreatment with acetaminophen on function and ultrastructure in the postischemia, reperfused myocardium was investigated (21). In that experiment, 0.35 mmol/l acetaminophen was administered 20 min before the onset of a 20-min period of global, low-flow myocardial ischemia followed by 40 min of reperfusion. Thus hearts in that study were exposed to acetaminophen for ~40 min before the onset of reperfusion and for 80 min by the end of the period of reflow. In the present study, the same concentration of acetaminophen was administered 10 min after the onset of ischemia. By the time of reperfusion, these hearts had been treated for only 10 min with acetaminophen and for only 50 min by the end of the period of reflow. Still, acetaminophen-treated hearts regained a significantly greater fraction of their baseline, control function than vehicle-treated hearts during the period of reflow, and the myofibrillar ultrastructure was preserved. This comparison reveals that acetaminophen is efficacious during reperfusion even when administered midway through a brief period of ischemia. Whether or not hearts would be protected by administration of acetaminophen upon initiation of reperfusion remains to be seen.
Any functional and/or structural differences between vehicle- and acetaminophen-treated hearts in the current study cannot be explained on the basis of changes over time. In our timed, control protocol, we found that two groups of hearts receiving no treatments other than an initial administration of acetaminophen (0.35 mmol/l) and vehicle could not be differentiated statistically during the 90-min experimental period. It was clear, however, that a trend toward improved function with time occurred in the acetaminophen-treated hearts, i.e., all indexes of left ventricular mechanical function appeared to improve with time. Thus comparing the current results with those from our previous study suggests that the longer the myocardium is exposed to acetaminophen, the more efficacious it becomes. This implies that hearts treated chronically with acetaminophen might be expected to function better during ischemia-reperfusion than those treated with vehicle.
Hydrogen Peroxide and Acetaminophen
Exposure of the intact adult guinea pig myocardium to 0.1 mmol/l hydrogen peroxide for 15 min produced no significant, observable effects on the variables recorded in our current experiment. Conversely, as the concentration was increased to 0.25 and 0.4 mmol/l, there was considerable dysfunction, as evidenced by the marked reductions in ventricular contractile function. Although not shown here, several vehicle-treated hearts in preliminary experiments fibrillated after a few minutes of exposure to concentrations of 0.4-1.0 mmol/l hydrogen peroxide. These concentrations resulted in rapid and precipitous decrements in left ventricular function. In the same preliminary experiments, ventricular fibrillation was not seen when acetaminophen-treated hearts were exposed to similarly high concentrations of hydrogen peroxide.The effects of hydrogen peroxide on the mammalian myocardium are influenced, among other things, by the tissue preparations and hydrogen peroxide concentrations being investigated (6, 14). There is some evidence of protein damage, and target proteins include extracellular signal-regulated kinases, mitogen-activated protein kinases, and native myoglobin, to name a few (3, 8). Many of the pathophysiological effects of hydrogen peroxide can be prevented by a 15-min pretreatment with 0.2 mmol/l salicylaldehyde isonicotinoyl hydrazone (SIH). This novel lipophilic iron chelator is known to attenuate the oxidative stress of hydrogen peroxide by reducing its ability to release hydroxyl radical via the Fenton reaction (2, 14).
We did not quantify the electrophysiological effects of hydrogen peroxide in the current study but did note its ability, in both groups, to produce occasional ventricular premature beats (VPB) and salvos (VS) (data not shown). It has been previously reported that acetaminophen can reduce the incidence of pentobarbital sodium-induced VPBs and VS (19), but the influence of acetaminophen on hydrogen peroxide-induced ventricular arrhythmias was not investigated nor was electronmicroscopy of the hydrogen peroxide-damaged myocardium done. However, acetaminophen is able to attenuate the production of hydroxyl radicals during reperfusion (21). Thus it seems reasonable to suggest that the protective effects of acetaminophen against hydrogen peroxide are mediated via a similar mechanism, i.e., by inhibition of the actions of hydroxyl radicals released from hydrogen peroxide in the Fenton reaction (2, 14).
Ischemia-Reperfusion, Peroxynitrite, and Acetaminophen
There is still general controversy over the potential toxic versus beneficial effects of peroxynitrite in the mammalian myocardium (11, 23). We chose to study peroxynitrite during ischemia-reperfusion injury because of its ability to be detected by chemiluminescence (30, 31), a relatively simple chemical assay. In our experiments, peroxynitrite was generated from the coproduction of nitric oxide and superoxide. These two precursors, in turn, were donated via a cascade of oxidation/reduction reactions beginning with exogenous linsidomine (SIN-1).When 0.35 mmol/l acetaminophen was administered midway through a 20-min period of global, low-flow myocardial ischemia, hearts regained greater contractile function during the subsequent period of reperfusion than vehicle-treated hearts. Coronary venous perfusate samples collected in vehicle-treated hearts displayed greater chemiluminescence during reperfusion than those collected from hearts treated with acetaminophen. These results are qualitatively similar to those obtained when the same concentration of acetaminophen was administered 20 min before the onset of low-flow ischemia. Moreover, when peroxynitrite was sequestered by urate, it was unable to oxidize luminol to produce the blue light of chemiluminescence. Thus urate had effects similar to those of acetaminophen. The mechanism of acetaminophen-mediated cardioprotection in the current study appears to be similar to that seen when acetaminophen was administered before the onset of ischemia (21), i.e., attenuation of the oxidation of luminol by peroxynitrite. Peroxynitrite is a potent oxidant, and, like hydrogen peroxide, hydroxyl radical, and other reactive oxygen species, peroxynitrite can alter the structure and function of nucleic acids, proteins, lipids, and other macromolecules (11, 17, 33, 35). Thus, by attenuating the damaging effects of powerful cytotoxic oxidants, acetaminophen is able to preserve the structural integrity and physiological function of the mammalian myocardium.
Ischemia-Reperfusion, Protein Oxidation, and Acetaminophen
Gow et al. (13) and Ischiropoulos and Al-Mehdi (15) have reported peroxynitrite-mediated oxidative injury to proteins. Powell and Tortolani (25) have reported the ability of antioxidants, including salicylate, to protect against such injury during ischemia and reperfusion in isolated rodent hearts. Our measurement of cytosolic protein carbonyls, another expression of tissue damage, gives additional information about the antioxidant, cytoprotective properties of acetaminophen. The content of protein carbonyls in the injured myocardium treated with acetaminophen was significantly less during ischemia than was seen in vehicle-treated hearts. However, after 40 min of reperfusion, protein carbonyls were still elevated in both groups. Thus whatever protective effect acetaminophen had during ischemia appeared to wane during reperfusion. More work is needed to explain this phenomenon and to begin identifying specific proteins that are spared during ischemia. From our electronmicrographs and the data of others (8, 23, 24), it seems apparent that both functional and structural proteins are involved.Limitations
While isolated, perfused rodent hearts, such as the Langendorff preparation used in the current study, offer several advantages over other preparations (e.g., elimination of confounding neurogenic factors, ease of methodology, etc.), they do have significant limitations. We used a crystalloid perfusate as opposed to one with colloid (e.g., bovine serum albumin) and/or cellular elements. The potential problems associated with the disposition of peroxynitrite of differing perfusates are still under debate (18, 27). For example, red blood cells, in addition to improving the oxygen content of the perfusate, can release/take up glutathione, which in turn can modify the metabolism of peroxynitrite (32).Summary and Conclusions
In the isolated, perfused guinea pig heart exposed to low-flow global myocardial ischemia and reperfusion, acetaminophen is cardioprotective. In a previous study, the efficacy when acetaminophen was administered ~20 min before the onset of ischemia was described (21). It is evident from the current study that acetaminophen is efficacious even when administered during ischemia. This significant difference advances our understanding of the time course of the cardioprotective actions of acetaminophen. It supports the need to continue the investigation by administering acetaminophen at the onset of reperfusion and to look at other time frames as well. Antioxidant mechanisms involving peroxynitrite, hydroxyl radical, and hydrogen peroxide appear to be involved. Additional studies are needed to determine the ability of acetaminophen to influence other perturbations, e.g., cytokine- and hypoxia/reoxygenation-mediated tissue injury.| |
ACKNOWLEDGEMENTS |
|---|
This work was supported, in part, by a grant from McNeil Consumer Healthcare (Fort Washington, PA) and from Johnson & Johnson, COSAT (New Brunswick, NJ).
| |
FOOTNOTES |
|---|
10.1152/ajpheart.00716.2001
Address for reprint requests and other correspondence: G. F. Merrill, Dept. of Cell Biology and Neuroscience, Rutgers Univ., 604 Allison Rd., Piscataway, NJ 08854.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 10 August 2001; accepted in final form 28 November 2001.
| |
REFERENCES |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1.
Ameer, B,
and
Greenblatt J.
Pharmacological review of paracetamol (acetaminophen).
Ann Intern Med
87:
202,
1977.
2.
Biondi, R,
Xia Y,
Rossi R,
Paolocci N,
Ambrosio G,
and
Zweier JL.
Detection of hydroxyl radicals by D-phenylalanine hydroxylation: a specific radical generation in biological systems.
Anal Biochem
290:
138-145,
2001[Web of Science][Medline].
3.
Bogoyevitch, MA,
Ng DC,
Court NW,
Draper KA,
Dhillon A,
and
Abas L.
Intact mitochondrial electron transport function is essential for signaling by hydrogen peroxide in cardiac myocytes.
J Mol Cell Cardiol
32:
1469-1480,
2000[Web of Science][Medline].
4.
Bunger, R,
Haddy FJ,
and
Gerlach E.
Coronary responses to dilating substances and competitive inhibition by theophylline in the isolated perfused guinea pig heart.
Pflügers Arch
353:
212-224,
1975.
5.
Bunger, R,
Haddy FJ,
Querengasser A,
and
Gerlach E.
An isolated guinea pig heart preparation with in vivo-like features.
Pflügers Arch
353:
317-326,
1975[Web of Science][Medline].
6.
Chen, QM,
Tu VC,
Wu Y,
and
Bahl JJ.
Hydrogen peroxide dose dependent induction of cell death or hypertrophy in cardiomyocytes.
Arch Biochem Biophys
373:
242-248,
2000[Web of Science][Medline].
7.
Colletti, AE,
Vogl HW,
Rahe T,
and
Zambraski EJ.
Effects of acetaminophen and ibuprofen on renal function in anesthetized normal and sodium-depleted dogs.
J Appl Physiol
86:
592-597,
1999
8.
Egawa, T,
Shimada H,
and
Ishimura Y.
Formation of compound I in the reaction of native myoglobins with hydrogen peroxide.
J Biol Chem
275:
34858-34866,
2000
9.
Fairbrothers, JE.
Paracetamol: a comprehensive description.
In: Analytical Profiles of Drug Substances, edited by Florey K.. New York: Academic, 1974, vol. 3, p. 1-109.
10.
Farquhar, WB,
Morgan AL,
Zambraski EJ,
and
Kenney WL.
Effects of acetaminophen and ibuprofen on renal function in the stressed kidney.
J Appl Physiol
86:
598-604,
1999
11.
Ferdinandy, P,
and
Schulz R.
Peroxynitrite: toxic or protective in heart.
Circ Res
88:
E12-E13,
2001.
12.
Gilman, AG,
Rall TW,
Nies AS,
and
Taylor P.
Goodman and Gilman's The Pharmacological Basis of Therapeutics (8th ed.). New York: Pergamon, 1990, p. 656-659 and 1655.
13.
Gow, JA,
Duran D,
Malcolm S,
and
Ischiropoulos H.
Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation.
FEBS Lett
385:
53-55,
1993.
14.
Horackova, M,
Ponka P,
and
Byczko Z.
The antioxidant effects of novel iron chelator salicylaldehyde isonicotinyol hydrazone in the prevention of H2O2 injury in adult cardiomyocytes.
Cardiovasc Res
47:
529-536,
2000
15.
Ischiropoulos, H,
and
Al-Mehdi AB.
Peroxynitrite-mediated oxidative protein modifications.
FEBS Lett
364:
282-297,
1995.
16.
Kang, YH,
Wei HM,
and
Merrill GF.
Role of adenosine in catecholamine-induced coronary functional hyperemia.
J Cardiovasc Pharmacol
15:
940-946,
1990.
17.
Liu, P,
Hock CE,
Nagele R,
and
Wong PYK
Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats.
Am J Physiol Heart Circ Physiol
272:
H2327-H2336,
1997
18.
Ma, XL,
Gao F,
Lopez BL,
Christopher TA,
and
Vinten-Johansen J.
Peroxynitrite, a two-edged sword in post-ischemic myocardial injury. Dichotomy of action in crystalloid versus blood-perfused hearts.
J Pharmacol Exp Ther
292:
912-920,
2000
19.
Merrill, G,
and
Goldberg E.
Antioxidant properties of acetaminophen and cardioprotection.
Bas Res Cardiol.
96:
422-429,
2001.
20.
Merrill, GF,
Haddy FJ,
and
Dabney JM.
Adenosine, theophylline, and perfusate pH in the isolated perfused guinea pig heart.
Circ Res
42:
225-229,
1978
21.
Merrill, G,
McConnell P,
VanDyke K,
and
Powell S.
Coronary and myocardial effects of acetaminophen: protection during ischemia-reperfusion.
Am J Physiol Heart Circ Physiol
280:
H2631-H2638,
2001
22.
Nakamoto, K,
Kamisaki Y,
Wada K,
Kawasaki H,
and
Itoh T.
Protective effect of acetaminophen against acute gastric mucosal lesions induced by ischemia-reperfusion in the rat.
Pharmacology
54:
203-210,
1997[Web of Science][Medline].
23.
Nakazawa, H,
Fukuyama N,
Takizawa S,
Tsuji C,
Yoshitake M,
and
Ishida H.
Nitrotyrosine formation and its role in various pathological conditions.
Free Radic Res
33:
771-784,
2000[Web of Science][Medline].
24.
Nishida, M,
Maruyama Y,
Tanaka R,
Kontani K,
Nagao T,
and
Kurose H.
Gi
and Go are target proteins of reactive oxygen species.
Nature
408:
492-495,
2000[Medline].
25.
Powell, SR,
and
Tortolani AJ.
Recent advances in the role of reactive oxygen intermediates in ischemic injury.
J Surg Res
53:
417-429,
1992[Web of Science][Medline].
26.
Prescott, LF.
Paracetamol (Acetaminophen): A Critical Bibliographic Review. London: Taylor and Francis, 1996.
27.
Ronson, RS,
Thourani VH,
Ma XL,
Katzmark S,
Han D,
Zhao ZQ,
Nakamura M,
Guyton RA,
and
Vinten-Johansen J.
Peroxynitrite, the breakdown product of nitric oxide, is beneficial in blood cardioplegia but injurious in crystalloid cardioplegia.
Circulation
100, Suppl II:
II384-II391,
1999.
28.
Schacter, E,
Williams JA,
Lim M,
and
Levine RL.
Differential susceptibility of plasma proteins to oxidative modification: examination by Western blot immunoassay.
Free Radic Biol Med
17:
429-437,
1994[Web of Science][Medline].
29.
Stowe, DF.
Vasodilator responses to moderate hypoxia after submaximal adenosine injection or coronary occlusion in isolated perfused guinea pig hearts.
Circ Res
47:
392-399,
1980
30.
VanDyke, K,
McConnell P,
and
Marquardt L.
Green tea extract and its polyphenols markedly inhibit luminol-dependent chemiluminescence activated by peroxynitrite or SIN-1.
Luminescence
15:
37-43,
2000[Web of Science][Medline].
31.
VanDyke, K,
Sacks M,
and
Qazi N.
A new screening method to detect water-soluble antioxidants: acetaminophen and other phenols react as antioxidants and destroy peroxynitrite-based luminol-dependent chemiluminescence.
J Biolumin Chemilumin
13:
339-348,
1998[Web of Science][Medline].
32.
Vinten-Johansen, J.
Physiological effects of peroxynitrite: potential products of the environment.
Circ Res
87:
170-172,
2000
33.
Wang, P,
and
Zweier JL.
Measurements of nitric oxide and peroxynitrite generation in the postischemic heart.
J Biol Chem
271:
29223-29230,
1996
34.
Wei, HM,
Kang YH,
and
Merrill GF.
Adenosine's role in the coronary vasodilation of global myocardial hypoxia: effects of adenosine deaminase.
Am J Physiol Heart Circ Physiol
254:
H1004-H1009,
1988
35.
Yasmin, W,
Strynakada KD,
and
Schulz R.
Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts.
Cardiovasc Res
33:
422-432,
1997
This article has been cited by other articles:
|
|
 |
|
  N. M. Hadzimichalis, S. S. Baliga, R. Golfetti, K. M. Jaques, B. L. Firestein, and G. F. Merrill Acetaminophen-mediated cardioprotection via inhibition of the mitochondrial permeability transition pore-induced apoptotic pathway Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3348 - H3355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Merrill, J. H. Merrill, R. Golfetti, K. M. Jaques, N. S. Hadzimichalis, S. S. Baliga, and T. H. Rork Antiarrhythmic Properties of Acetaminophen in the Dog Experimental Biology and Medicine, October 1, 2007; 232(9): 1245 - 1252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Chen, A. K. S. Camara, D. F. Stowe, C. L. Hoppel, and E. J. Lesnefsky Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion Am J Physiol Cell Physiol, January 1, 2007; 292(1): C137 - C147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. G. Leshnower, H. Sakamoto, A. Zeeshan, L. M. Parish, R. Hinmon, T. Plappert, B. M. Jackson, J. H. Gorman III, and R. C. Gorman Role of acetaminophen in acute myocardial infarction Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2424 - H2431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Kevin, E. Novalija, and D. F. Stowe Reactive Oxygen Species as Mediators of Cardiac Injury and Protection: The Relevance to Anesthesia Practice Anesth. Analg., November 1, 2005; 101(5): 1275 - 1287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Rork, K. Van Dyke, N. M. Spiler, and G. F. Merrill Acetaminophen in the Hypoxic and Reoxygenated Guinea Pig Myocardium Experimental Biology and Medicine, December 1, 2004; 229(11): 1154 - 1161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Merrill, T. H. Rork, N. M. Spiler, and R. Golfetti Acetaminophen and myocardial infarction in dogs Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1913 - H1920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Dai and R. A. Kloner Effects of Acetaminophen on Myocardial Infarct Size in Rats Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2003; 8(4): 277 - 284. [Abstract] [PDF]
|
|
|
|
|
|
R. Golfetti, T. Rork, and G. Merrill Chronically Administered Acetaminophen and the Ischemia/Reperfused Myocardium Experimental Biology and Medicine, June 1, 2003; 228(6): 674 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Golfetti, K. VanDyke, T. Rork, N. Spiler, and G. Merrill Acetaminophen in the Post-ischemia Reperfused Myocardium Experimental Biology and Medicine, December 1, 2002; 227(11): 1031 - 1037. [Abstract] [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
